You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰林生物(300813.SZ):2023年度淨利潤預降66.12%-77.41%
格隆匯 01-30 16:01

格隆匯1月30日丨泰林生物(300813.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利1,800萬元–2,700萬元,比上年同期下降77.41%-66.12%;扣除非經常性損益後的淨利潤盈利1,100萬元–1,650萬元,比上年同期下降84.87%-77.31%。

報吿期內,公司歸屬於上市公司股東的淨利潤較上年同向下降的主要原因為:1.報吿期內,部分客户要求的交驗週期有所延長以及子公司搬遷新園區車間的裝修改造等因素影響,公司的環境控制產品系列(隔離技術系列)和滅菌技術系列產品的銷售收入同比有所下降。2.報吿期內,公司持續加大研發投入,積極拓展新技術和新產品研發,公司在研發費用投入同比有所增長。3.公司積極開拓市場,展會和推廣費等同比有所增長,整體期間費用較上年同期有所增長。4.報吿期內,部分客户的回款低於預期,按照公司的會計政策計提的信用減值損失較上年同期增加較多。整體上,目前公司業務經營情況正常,在手訂單穩定,現金流充足,生產經營各方面未出現重大不利變化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account